These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 148873)

  • 1. Photoallergic dermatitis from 8-methoxypsoralen.
    Plewig G; Hofmann C; Braun-Falco O
    Arch Dermatol Res; 1978 Apr; 261(2):201-11. PubMed ID: 148873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1977 Nov; 28(11):583-8. PubMed ID: 599020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
    Meffert H; Andersen KE; Sönnichsen N
    Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylaxis to 5-methoxypsoralen during photochemotherapy.
    Legat FJ; Wolf P; Kränke B
    Br J Dermatol; 2001 Nov; 145(5):821-2. PubMed ID: 11736909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications.
    Plewig G; Hofmann C; Braun-Falco O; Nath G; Kreitmair A
    Br J Dermatol; 1978 Jan; 98(1):15-24. PubMed ID: 626711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
    McNeely W; Goa KL
    Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Semen analysis under photochemotherapy (PUVA-therapy) (author's transl)].
    Schill WB; Hofmann C; Plewig G
    Arch Dermatol Res; 1979 Mar; 264(2):153-60. PubMed ID: 464634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
    Koulu L; Jansén CT
    Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic photoallergy induced by methoxalen].
    Jeanmougin M; Manciet JR; Castelneau JP; Smadja J; Dubertret L
    Ann Dermatol Venereol; 1992; 119(4):277-80. PubMed ID: 1530240
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A; Ortel B; Rappersberger K; Hönigsmann H
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of acute myeloid leukaemia in a patient with psoriasis treated with oral 8-methoxypsoralen and longwave ultraviolet light.
    Hansen NE
    Scand J Haematol; 1979 Jan; 22(1):57-60. PubMed ID: 284581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis.
    Swanbeck G; Ehrsson H; Ehrnebo M; Wallin I; Jonsson L
    Clin Pharmacol Ther; 1979 Apr; 25(4):478-80. PubMed ID: 428192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis.
    Stephens RB; Cooper A
    Australas J Dermatol; 1999 Nov; 40(4):217-9. PubMed ID: 10570561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver biopsy in PUVA-treated patients.
    Zachariae H; Kragballe K; Søgaard H
    Acta Derm Venereol; 1979; 59(3):268-70. PubMed ID: 87091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous drug eruption caused by 8-methoxypsoralen.
    Cox NH; Rogers S
    Photodermatol; 1989 Apr; 6(2):96-7. PubMed ID: 2526323
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.